Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,409 across all filing types
Latest filing 2026-02-10 Regulatory Filings
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
6-K Filing
Regulatory Filings
2026-02-10 English
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Disclosure of trading in own shares' and contains detailed tables listing transaction dates, volumes, and identifiers for share purchases. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of companies buying back their own shares.
2026-02-09 English
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is titled 'Désignation des transactions sur actions propres' (Designation of transactions in own shares) and contains detailed tables listing transaction dates, identifiers, and quantities of shares. This is a standard regulatory disclosure for share buyback programs. According to the provided definitions, 'Transaction in Own Shares' (POS) is the specific category for reports of a company buying back or selling its own shares.
2026-02-09 English
6-K Filing
Regulatory Filings
2026-02-06 English
S-8 POS Filing
Regulatory Filings
2026-02-05 English
Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat d'actions pour un montant maximum de 1 milliard d’euros
Transaction in Own Shares Classification · 100% confidence The document is a press release from Sanofi announcing the signing of a mandate to repurchase its own shares for a maximum amount of 1 billion euros. This falls directly under the category of 'Transaction in Own Shares' (POS), which covers share buyback announcements.
2026-02-03 French

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.